Epix Pharmaceuticals
This article needs additional citations for verification. (June 2015) |
Epix Pharmaceuticals Inc (formerly Predix Pharmaceuticals Inc) was a
pharmaceutical company based in Lexington, Massachusetts
.
Its products included the following agents:[citation needed]
- major depression and generalized anxiety disorder
- 5-HT4 receptor partial agonist: for Alzheimer's disease
- 5-HT6 receptor antagonist: for obesity and cognitive impairment associated with Alzheimer's disease and schizophrenia
- 5-HT2B receptor antagonist: for pulmonary hypertension associated with chronic obstructive pulmonary disease
As of July 2009, the company was in the process of asset liquidation due to insufficient funds to stay afloat.[1]
References
- ^ Weisman, Robert (22 July 2009). "Epix Pharmaceuticals of Lexington is latest biotech to fall to funding crunch". The Boston Globe. Retrieved 23 November 2011.
External links